Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Gordon

Showing results (121-130 of 262) with videos related to

Pageof 27
Sort By:
Neuroimage|April 22, 2022
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer diseasePeter R Millar, Patrick H Luckett, Brian A Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2026
Blood-based proteomic signature of amyloidosis: identification of novel regulators of amyloid loadYike Chen, Michael R Duggan, Jigyasha Timsina, et al.
Nature Communications|September 10, 2021
Accelerated functional brain aging in pre-clinical familial Alzheimer's diseaseJulie Gonneaud, Alex T Baria, Alexa Pichet Binette, et al.
Molecular Neurodegeneration|November 18, 2025
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohortKatherine Gong, Jigyasha Timsina, Muhammad Ali, et al.
Research Square|July 18, 2025
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed dementia cohortKatherine Gong, Jigyasha Timsina, Muhammad Ali, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Neurology|February 14, 2018
In vivo [<sup>18</sup>F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob diseaseGregory S Day, Brian A Gordon, Richard J Perrin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumShaney Flores, Thomas Hunter Smith, Jalen Scott, et al.
Pageof 27

Showing results (121-130 of 262) with videos related to

Sort By:
Pageof 27
Neuroimage|April 22, 2022
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer diseasePeter R Millar, Patrick H Luckett, Brian A Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2026
Blood-based proteomic signature of amyloidosis: identification of novel regulators of amyloid loadYike Chen, Michael R Duggan, Jigyasha Timsina, et al.
Nature Communications|September 10, 2021
Accelerated functional brain aging in pre-clinical familial Alzheimer's diseaseJulie Gonneaud, Alex T Baria, Alexa Pichet Binette, et al.
Molecular Neurodegeneration|November 18, 2025
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohortKatherine Gong, Jigyasha Timsina, Muhammad Ali, et al.
Research Square|July 18, 2025
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed dementia cohortKatherine Gong, Jigyasha Timsina, Muhammad Ali, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Neurology|February 14, 2018
In vivo [<sup>18</sup>F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob diseaseGregory S Day, Brian A Gordon, Richard J Perrin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumShaney Flores, Thomas Hunter Smith, Jalen Scott, et al.
Pageof 27